Octant
Jorge Conde is the current Director at Octant. Jorge was previously the CEO at IDRx and Vicinitas Therapeutics. Jorge has also worked as the Chief Business Officer at Dyno Therapeutics and EQRx. Prior to that, they were a Principal at Komodo Health and Asimov. Jorge has also worked at Octant and Tmunity Therapeutics Incorporated as an Associate. Jorge began their career as an analyst at Andreessen Horowitz.
Jorge Conde has a Master of Business Administration from Harvard Business School, a Master of Science in the Biomedical Enterprise Program from the Massachusetts Institute of Technology, and a Bachelor of Arts in Biology from The Johns Hopkins University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Octant
2 followers
Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs.